We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
AUM
$1.23B
AUM Growth
Cap. Flow
+$1.06B
Cap. Flow %
86.51%
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.04%
2 Technology 0.89%
3 Consumer Discretionary 0.79%
4 Industrials 0.61%
5 Consumer Staples 0.61%

Similar funds

Vantage Consulting Group's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.

Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.

  • Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
  • Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
  • Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.

Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.